A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma

NCT00281541 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

DRUG: YM155

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]